Literature DB >> 24262938

Association between telephone activity and features of patients with inflammatory bowel disease.

Claudia Ramos-Rivers1, Miguel Regueiro1, Eric J Vargas1, Eva Szigethy2, Robert E Schoen1, Michael Dunn1, Andrew R Watson3, Marc Schwartz1, Jason Swoger1, Leonard Baidoo1, Arthur Barrie1, Anwar Dudekula4, Ada O Youk5, David G Binion6.   

Abstract

BACKGROUND & AIMS: Telephone communication is common between healthcare providers and patients with inflammatory bowel disease (IBD). We analyzed telephone activity at an IBD care center to identify disease and patient characteristics associated with high levels of telephone activity and determine if call volume could identify individuals at risk for future visits to the emergency department (ED) or hospitalization.
METHODS: We performed a prospective observational study in which we categorized telephone calls received by nursing staff over 2 years at a tertiary care IBD clinic (2475 patients in 2009 and 3118 in 2010). We analyzed data on 21,979 ingoing and outgoing calls in 2009 and 32,667 calls in 2010 and assessed associations between clinical factors and logged telephone encounters, and between patterns of telephone encounters and future visits to the ED or hospitalization.
RESULTS: Telephone encounters occurred twice as frequently as office visits; 15% of the patients generated >10 telephone encounters per year and were responsible for half of all telephone encounters. A higher percentage of these high telephone encounter (HTE) patients were female, had Crohn's disease, received steroid treatment, had increased levels of C-reactive protein and rates of erythrocyte sedimentation, had psychiatric comorbidities, and had chronic abdominal pain than patients with lower telephone encounters. The HTE patients were also more frequently seen in the ED or hospitalized over the same time period and in subsequent years. Forty-two percent of patients with >8 telephone encounters within 30 days were seen in the ED or hospitalized within the subsequent 12 months.
CONCLUSIONS: Based on an analysis of telephone records at an IBD clinic, 15% of patients account for half of all calls. These HTE patients are a heterogeneous group with refractory disease who are likely to visit the ED or be hospitalized.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Crohn's Disease; Depression; Electronic Medical Record; Short Inflammatory Bowel Disease Questionnaire; Telephone Calls; Ulcerative Colitis

Mesh:

Year:  2013        PMID: 24262938      PMCID: PMC4031304          DOI: 10.1016/j.cgh.2013.11.015

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  17 in total

1.  Narcotic use in patients with Crohn's disease.

Authors:  Raymond K Cross; Keith T Wilson; David G Binion
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

2.  Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study.

Authors:  Karen A Hanson; Edward V Loftus; W Scott Harmsen; Nancy N Diehl; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

3.  Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.

Authors:  Craig A Solem; Edward V Loftus; William J Tremaine; William S Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2005-08       Impact factor: 5.325

4.  Medical advice by telephone at Swedish health centres: who calls and what are the problems?

Authors:  B Marklund; C Bengtsson
Journal:  Fam Pract       Date:  1989-03       Impact factor: 2.267

5.  The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis.

Authors:  S L Jowett; C J Seal; J R Barton; M R Welfare
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

6.  The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.

Authors:  E J Irvine; Q Zhou; A K Thompson
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

7.  Telephone care as a substitute for routine clinic follow-up.

Authors:  J Wasson; C Gaudette; F Whaley; A Sauvigne; P Baribeau; H G Welch
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

8.  Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study.

Authors:  Eva Szigethy; Anna Levy-Warren; Sarah Whitton; Athos Bousvaros; Kimberlee Gauvreau; Alan M Leichtner; William R Beardslee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-10       Impact factor: 2.839

9.  Permanent work disability in Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Lydia R Weber; Josh F Knox; Susan Skaros; Jeanne Emmons; Sarah Lundeen; Mazen Issa; Mary F Otterson; David G Binion
Journal:  Am J Gastroenterol       Date:  2007-12-11       Impact factor: 10.864

10.  Characteristics and perceptions of after-hours callers.

Authors:  S Evens; P Curtis; A Talbot; C Baer; A Smart
Journal:  Fam Pract       Date:  1985-03       Impact factor: 2.267

View more
  25 in total

1.  The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.

Authors:  Ioannis E Koutroubakis; Claudia Ramos-Rivers; Miguel Regueiro; Efstratios Koutroumpakis; Benjamin Click; Marc Schwartz; Jason Swoger; Leonard Baidoo; Jana G Hashash; Arthur Barrie; Michael A Dunn; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

2.  Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.

Authors:  Mimi C Tan; Hashem B El-Serag; Jason K Hou
Journal:  Dig Dis Sci       Date:  2016-12-23       Impact factor: 3.199

3.  Predicting Costs of Care for Patients With Inflammatory Bowel Diseases.

Authors:  Benjamin Click; David G Binion; Alyce M Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-03       Impact factor: 11.382

4.  Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

5.  Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Efstratios Koutroumpakis; Claudia Ramos-Rivers; Miguel Regueiro; Jana G Hashash; Arthur Barrie; Jason Swoger; Leonard Baidoo; Marc Schwartz; Michael A Dunn; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-10-29       Impact factor: 3.199

6.  Telemanagement for inflammatory bowel disease.

Authors:  Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

Review 7.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

8.  Using Institutional Databases to Study Inflammatory Bowel Disease.

Authors:  David Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-04

9.  Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.

Authors:  Julajak Limsrivilai; Ryan W Stidham; Shail M Govani; Akbar K Waljee; Wen Huang; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-17       Impact factor: 11.382

10.  Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.

Authors:  Toufic A Kabbani; Ioannis E Koutroubakis; Robert E Schoen; Claudia Ramos-Rivers; Nilesh Shah; Jason Swoger; Miguel Regueiro; Arthur Barrie; Marc Schwartz; Jana G Hashash; Leonard Baidoo; Michael A Dunn; David G Binion
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.